Des-acylated ghrelin was negatively associated with subclinical atherosclerosis in middle-aged women with metabolic syndrome, as assessed by carotid artery intima-media thickness, suggesting gender-specific effects of the des-acylated ghrelin in the development of atherosclerosis [94]. This evidence concerns the gene GHRL and metabolic syndrome.